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Activation of leukocytes is the initial step in the multistep process of inflammation.
The inflammatory response is characterized by closely intertwined humoral and
cellular components. During this process leukocytes, in particular neutrophils and
monocytes, are initially triggered by proinflammatory mediators or bacterial products,
such as endotoxin, in order to optimally perform their task. Upon activation, circulating
leukocytes adhere to and transmigrate through the activated endothelial monolayer.
Activation of endothelial cells is a prerequisite for neutrophil adherence to and
transmigration through the endothelial monolayer. Guided by a concentration gradient
of chemoattractants, these activated neutrophils migrate towards the site of infection.
Adhesion molecules play a central role in this process of adherence and transmigration
'0. Once there, these activated neutrophils and monocytes recognize, phagocytose and
subsequently kill the invading microorganisms. Neutrophils and monocytes possess a
whole arsenal of intracellularly stored enrymes, which serve to kill and degrade
phagocytosed material. In addition, these cells are capable of, when activated,
producing and secreting reactive oxygen species (ROS) for this same purpose. When,
however, released uncontrolled, these products are harmful to surrounding cells '. This
uncontrolled release of lytic enzymes and oxygen radicals is thought to play an
important role in the pathophysiology of inflammatory disorders, such as ANCA
associated vasculitides and sepsis. Both inflammatory diseases are characterized by
systemic inflammation and leukocyte activation, but differ markedly in clinical
manifestation. This thesis focuses on the relation between leukocyte activation and its
role in the pathophysiology and clinical manifestations in both ANCA associated
vasculitides and sepsis, as outlined in chapter I .
PART I: LEUKOCYTE ACTIVATION IN ANCA ASSOCIATED
VASCULITIDES
Cell biological mechanisms of renal diseuse: Pathophysiologlt of ANCA associated
vasculitides
In viíro experiments have demonstrated that anti-neutrophil cytoplasmic antibodies
(ANCA) are capable of activating neutrophils and monocytes. Little is known,
however, of the in vivo relevance of these in vitro observed effects of ANCA and how
these effects may finally result in in vivo systemic inflammation, damage of blood
vessels and pauci-immune glomerulonephritis. In chapter 2 the intemational iterature,
including some of the work described in this thesis, on ANCA, leukocyte activation
and its role in the pathophysiology of ANCA associated vasculitides is reviewed.
Particular attention is given to the relation between those ln vitro findings and the ln












































































Summary and General Discussion
Leukocyte membrane expression of proteinase 3 correlaíes with disease activity in
patienís with ll/egener's gronulomaíosis
ANCA in patients with Wegener's granulomatosis (WG), one of the idiopathic
systemic vasculitides, are directed against proteinase 3 (Pr3) in most of the cases. As
reviewed in chapter 2, upon neutrophil priming in vitro, ANCA antigens, including Pr3
are expressed on the cell surface of neutrophils and monocytes, thereby becoming
available for interaction with ANCA t8'66. This inter.action, subsequently, results in
activation of these cells 16'tt. Sin"" ANCA can only interact with leukocytes when the
ANCA antigens are present on the cell surface, we investigated in chapter 3 whether
Pr3 was expressed on the membranes of circulating granulocytes and monocytes of
patients with anti-Pr3 associated WG. In addition, we investigated whether Pr3
expression was related to disease activity, so explaining the systemic nature and
severity of the disease.
The expression of Pr3, and other ANCA antigens, that is, myeloperoxidase (MPO) and
elastase (HLE), was analyzed on circulating granulocytes and monocytes by
flowcytometry, using a non activating whole blood method. Disease activity was
quantitated using the Birmingham Vascultis Activity Score (BVAS). We found that the
expression of proteinase 3 on neutrophils was increased in patients with active WG
compared to patients with quiescent disease and healthy controls. On monocytes no
differences in Pr3 expression were found between those groups. Furthermore, the
expression of MPO and HLE did not differ between patient groups and healthy
controls. Upon follow up, the expression of Pr3 on neutrophils from patients with
active WG decreased when patients went into remission. Pr3 expression on neutrophils
correlated with disease activity, as expressed by the BVAS score, suggesting that the
availability of Pr3 for interaction with ANCA plays a central role in the disease
process.
Are circulating neutrophils intravascularly activoted in patients with ANCA
asso ciated v asc ulitides ?
Vascular injury in vasculitis may be due to activation of circulating neutrophils
resulting in their increased adhesiveness to locally activated endothelium (Shwartzman
phenomenon). Since upregulation of endothelial ICAM-I and VCAM-I, as a marker
for endothelial cell activation, was already demonstrated in biopsies from patients with
ANCA associated vasculitis 2e, thus enabling the interaction with cells expressing the
relevant adhesion molecules, we investigated in chapter 4 the expression of adhesion
molecules (CDllb, ICAM-I, VLA-4, L-selectin) and activation markers (CD66b,
CD64, CD63) on circulating neutrophils from patients with ANCA associated
vasculitis in comparison to their expression on cells from healthy volunteers and
patients with sepsis, a condition in which intravascular activation of neutrophils is
known to take place. In this study we found that the expression of activation markers,
but not the expression of adhesion molecules was increased on neutrophils from
patients with active vasculitis. The expression of CD63 and CD66b on neutrophils
conelated with disease activity as determined by the Birmingham Vasculitis Activity
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Chapter 12
Score (BVAS). In contrast to patients with active vasculitis, patients with sepsis
showed upregulation of all markers, including adhesion molecules, suggesting that
circulating neutrophils are fully activated in sepsis. We concluded that in ANCA
associated vasculitis, circulating neutrophils are not fully activated, but primed, since
they do not express increased levels of adhesion molecules like in sepsis or in the
Shwartzman reaction. These findings are compatible with the concept that in vivo
vascular damage in ANCA associated vasculitides does not occur due to a Shwarzman-
like reaction but only after ANCA induced neutrophil activation at the endothelial cell
surface 2'. It appears that p2 integrin mediated outside-in signaling saseems to be
instrumental in ANCA induced neutrophil activation.
Monocyte activaíion in patients with lVegener's granulomatosis
Most studies have focused on the capacity of ANCA to induce neutrophil activation.
Apart from neutrophils, however, also monocytes/macrophages play a pivotal role in
lesion development in WG. An important histopathological feature in patients with
WG is granulomatous inflammation. Granuloma formation is thought to result from
activated monocytes/macrophages which are locally present and which participate in
granuloma formation by syqt^fepying and secreting a variety of chemoattractants,
growth factors and cytokines rz+' rzo. Furthermore, monocytes/macrophages may induce
vascular damage by the production and secretion of reactive oxygen radicals and lytic
proteases. Monocytes also contain the ANCA antigens Pr3 and MPO in their granules.
Like neutrophils, they express ANCA antigens upon priming 18, which subsequently
may initiate a process of cell activation similar as has been described for neutrophils
after interaction with ANCA. In view of these findings, we evaluated in chapter 5 m
vrvo monocyte activation in patients with active or quiescent WG. Patients with sepsis
served as positive controls for intravascular monocyte activation. Monocyte activation
was analyzed by measuring plasma levels of soluble products of monocyte activation,
that is neopterin and interleukin-6, which reflect the state of activation of circulating,
adherent and transmigrated monocytes, and by quantitating the surface expression of
activation markers on circulating monocytes by flowcytometry. V/e found evidence
that monocytes, circulating or otherwise, are activated in patients with vasculitis,
although compared to patients with sepsis, all markers of monocyte activation were
lower. \ile concluded that disease activity in rWG correlates with the extent of
activation of monocytes, which is compatible with their role in the pathophysiology of
this disease.
In vitro neutrophil acíivation by antibodies to Pr3 and MPo from patients with
cr e s c entic g I o m er ulo n ep h r iíh
Patients with necrotizing crescentic glomerulonephritis (NCGN) and ANCA directed
against proteinase 3 (anti-Pr3) have been shown to faster deteriorate their renal
function and to have more active renal vasculitic lesions than patients with anti-
myeloperorydase (anti-MPo) antibodies 3r' 3t. since ANCA induced neutrophil

















































































glomeruionephritis, we investigated in chapter 6 rvhether anti-Pr3 antibodies were
capable of inducing a more pronounced activation of neutrophils in vitro than anti-
MPO antibodies. Neutrophil activation was determined by measuring the oxygen
radical fonnation and the release of granule constituents upon stimulation with ANCA
positive IgG preparations. We found that IgG fractions trom anti-Pr3 positive patients
lvith NCGN were lrore potent activators of primed neutrophils than IgG fractions from
anti-MPO positive patients. This is in agreement rvith our hypothesis that the faster
deterioration of renal function and the more active renal vasculitic lesions observed in
anti-Pr3 positive patients, in comparison to anti-MPO positive patients, is associated
with a higher neutrophil activating capacity of anti-Pr3 IgG of the former patients.
Can endothelisl cells be activsted by ANCA?
Activation of endothelial cells is a prerequisite for neutrophil adherence to and
transmigration through the endothelial monolayer. Furthennore, as discussed earlier,
B2 interaction, i.e. binding to ,an endothelial monolayer, is a prerequisite for ANCA
induced neutrophil activation ". In vivo, endothelial cell activation in patients rvith
ANCA associated vasculiti<les has been demonstrated by several investigators 2e' 126.
Endothelial cells may become activated upon the release of pro-inflammatory
mediators, such as fumor Necrosis Factor cr or Interleukin l. In addition, anti-
neutrophil cytoplasmic antibody (ANCA) have been demonstrated to activate
endothelial cells izr vitro34-37' o3'e6. The precise mechanisms by which ANCA might
activate endothelial cells is unclear. ANCA antigens, like proteinase 3 (Pr3) and
myeloperoxidase (MPO), may bind to endothelial cells er' e2 or alternatively be
expressed on the surface of endothelial cells, as was previously demonstrated for
proteinase 3, but not for MPO 
". 
Subsequently, these antigens may be recognized by
ANCA and this interaction may result in endothelial cell activation. Othenvise, anti-
endothelial cell antibodies (AECA) are directed against endothelial antigens a2 and are
often present in patients with ANCA associated vasculitides 4t'42'270' ttt. Th"r" AECA
may also be responsible for the previously described capacity of ANCA positive IgG
preparations to induce endothelial celi activation in vitro. Therefore, rve investigated in
chapter 7 the capacity of ANCA positive IgG fractions to activate endothelial cells in
vitro.We related endothelial cell activation to the presence of both ANCA and AECA
in these IgG preparations.
The extent of endothelial cell activation was assessed by measuring E-selectin
upregulation and the production of interleukin 6. We found that 39 Yo of the ANCA
positive IgG samples were capable of activating endothelial cells (either by inducing
IL-6 production and/or E-selectin expression). Sixty four percent of these endothelial
cell activating ANCA positive IgG samples contained AECA. In addition, AECA
positive sanples which induced endothelial cell activation had higher AECA titres
than samples that did not induce endothelial cell activation. Endothelial cell activation
by ANCA alone could only be attributed to 14 oÁ of the ANCA positive samples, all
these samples contained anti-Pr3 antibodies. We concluded that only a minority of
l 5 l
Chapter l2
anti-Pr3 ANCA positive samples induces endothelial cell activation by itself, whereas,
samples which also contain AECA are more likely to induce endothelial cell activation.
PART II: LEUKOCYTE ACTIVATION IN SEPSIS
HL/I-DR expression on monoc!íes as a prognostic marker snd s guide for
immunotheropy in sepíic patienls
Sepsis is not a homogeneous entity, but can be regarded as a spectrum ofpro-and anti-
inflammatory responses. The immune response in sepsis sholvs a bimodal pattern
consisting of an early, frequently exaggerated inflammatory response, follorved by a
state of hyporesponsiveness often referred to as the compensatory anti-inflammatory
response syndrome (CARS) 25. Leukocyte characteristics during these phases range
from an exaggerated cell activation towards cell anergy. In chapter 8 the intemational
literature concerning the diÍferent immune states in patients with sepsis was revie'"ved.
and new therapies guided by these immunomonitoring techniques are discussed. It was
concluded that insight into the disease state couid be a promising new approach to the
therapy of patients with sepsis.
Leukocyte sctivstion in sepsis; cotelutions with disease state ond mortality
In chapter 9 we investigated the hypothesis that poor outcome in patients with sepsis
is related to the severity of CARS, as reflected in the degree of leukocy'te activation.
We determined the degree of leukocy'te activation by analyzing the surface expression
of several activation markers, including HLA-DR, CD11b, ICAM-1, CD66b, CD63
and CD64 on neutrophils and monocy'tes and by determining plasma concentrations of
lactoferrin, interleukin 6, and neopterin at the time of patient inclusion. We related
these data to patient survival. Compared to healthy controls, we found increased
expression of all markers, except for HLA-DR, which was decreased, on both PMNs
and monocy'tes. In addition, the expression of CDllb on PMNs and ICAM-I on
monocytes was lower in patients who died compared to patients who survived.
Furthermore, the combined analysis of all activation markers appeared to be predictive
for survival in patients with sepsis.
Therefore, we concluded that in sepsis, both PMNs and monocy'tes are activated
compared to healthy controls. Horvever, poor prognosis was associated with a lower
expression of activation markers on monocltes and PMNs, suggesting that poor
outcome in these patients might have been due to the compensatory anti-inflammatory
response. Furthermore, the combined analysis of parameters of neutrophil and
monoc)'te activation appeared to be a promising new tool to investigate the presence of




































































Summary and General Discussion
Interleukin 10 und monocyte HLtl-DR expression in patients with sepsis
As discussed in the previous chapters an overwhelming systemic pro-inflammatory
reaction is frequently followed by an overactive compensatory anti-inflammatory
response (CARS) 25 in which leukocy'te function is impaired. The precise mechanisms
that are involved in the development of CARS are not well known. In patients with
sepsis a decreased monocyte HLA-DR surface expression can be demonstrated uring
CARS a6'47 FurtherÍnore, ongoing decreased expression of HLA-DR on monocytes
from patients with sepsis has predictive value for a fatal outcome 46' 272 . Since the
expression of HLA-DR on monocytes is downregulated by the anti-inflammatory
cytokine interleukin l0 48, we examined in chapter 10 the hypothesis that IL-10 is a
potential candidate for the induction of CARS.
We investigated the expression of HLA-DR on monocÍes in 2 patients with sepsis and
related our findings to plasma concentrations of interleukin-10 during follow up. We
demonstrated in one patient an episode of CARS, as defined as an HLA-DR expression
of less than 30 oá compared to healthy controls. This coincided with an increase of IL-
l0 plasma concentration and a protracted clinical recovery. HLA-DR expression of the
second patient did not decrease significantly and IL-10 levels remained low. We
concluded that the anti-inflammatory cytokine IL-10 when measured in combination
with HLA-DR expression may be a good way to determine the patient's individual
immune status. The use of IL-10 measurements alone in determining the patient's
individual immune status, should however still be investigated. We believe that this
finding may have therapeutic consequences, since patients with sepsis have to be
treated according to their individual immune status 45'47'210.
Levels of soluble FcyRilI correlate wilh disease severity in sepsis
As discussed in the previous chapters, neutrophil activation is thought to play a crucial
role in the pathogenesis of sepsis. During activation, neutrophils adhere to and migrate
through the endothelium. Therefore, the amount of circulating neutrophils does not
adequately reflect the total amount of neutrophils that are involved in the
pathophysiologic process of this condition. Therefore, in chapter 11 we tested the
hypothesis that the severity of sepsis is associated with the total body mass of
neutrophils as reflected in the plasma concentration of soluble Fcy receptor type III
(sFcyRIII). We measured soluble FoyRIII plasma concentrations in nineteen patients
with sepsis and related these data to clinical and laboratory parameters of disease
severity of these patients and to the extent of neutrophil activation. V/e found that
soluble FcyRIII levels were elevated compared to healthy controls and correlated with
disease severity as measured by the APACHE II score in sepsis patients. Markers of
cell activation were significantly increased in sepsis patients, but did not correlate with
the APACHE II score.
In conclusion, this study demonstrates that soluble FcyRIII, but not neutrophil




The work described in this thesis is lbcussed on the relation between leukocye
activation and its role in the pathophysiology and clinical manifestations in both
ANCA associated vasculitides and sepsis. Both inflammatory diseases are
characterized by systemic inflammation and leukoclte activation, but differ markedly
in clinical manifestation.
We found large differences in the extent of activation of circulating neutrophils and
monocltes patients with vasculitis compared to patients with sepsis.
Whereas in patients with sepsis circulating neutrophils are fully activated, in patients
with vasculitis circulating neutrophils are not fully activated, but'primed'. The
absence of increased expression of adhesion molecules on circulating neutrophils in
patients with vasculitis pointed to this conclusion 122. In patients with vasculitis these
circulating primed neutrophils express proteinase 3 and myeloperoxydase, the target
antigens for ANCA in both patients with vasculitis and patients with sepsis rr7. We
demonstrated that the expression of proteinase 3 on circulating neutrophils from
patients with vasculitis correlates with disease activity, as expressed by the BVAS
score, suggesting a role for priming and availability of the target antigen proteinase 3
in the disease processttt. Once neutrophils and monocytes express proteinase 3 or
myeloperoxydase, these cells can interact with ANCA. However, full activation of
neutrophils, as a result of stimulation by ANCA, occurs only when cells are bound to a
surface, that is, bound to endothelial cells 22. Thus, the close contact between
endothelial cells and neutrophils, that are locaily activated by ANCA, enables these
neutrophils to degranulate in the vicinity of endothelial cells, resulting in endothelial
cell injury and, eventually, vascular damage ', which does not occur in sepsis where
leukocytes are already intravascularly activated.
Most studies have focused on the capacity of ANCA to induce neutrophil activation.
Apart from neutrophils, however, also monocy'tes/macrophages play a pivotal role in
lesions developing in Wegener's granulomatosis. Furthermore, monocÍes also contain
the ANCA antigens Pr3 and MPO in their granules. Like neutrophils, they express
ANCA antigens upon priming l8' ll7, which subsequently may initiate a process of cell
activation, similar as has been described for neutrophils after interaction with ANCA,
We showed that circulating monocytes in patients with Wegener's granulomatosis are
activated, although less than in patients with sepsis, suggesting that these cells are also
only 'primed'. We further demonstrated that the extent of activation of these cells is
correlated with disease activity r25, which supports their role in the pathophysiology of
Wegener's granulomatosis, more in particular, in granuloma formation.
In patients with sepsis, however, no clear-cut correlation was found between cell
activation and disease severity, as expressed by the APACHE II score tot. The immune
response in sepsis shows a bimodal pattem consisting of an early, frequently
exaggerated inflammatory response, followed by a state of hyporesponsiveness^often
referred to as the compensatory anti-inflammatory response syndrome (CARS) ". We






























































Summary and General Discussion
fully activated, it appears that in those patients, a relatively diminished cell activation
of monocytes, but also neutrophils, is associated with a poor survival lae. This
phenomenon can be attributed to a state of CARS. Furthermore, a state of CARS can
be identified by a decreased expression of HLA-DR on monocytes, which coincides
with increased plasma concentrations of the anti-inflammatory cytokine IL-10'22.IL-
l0 appears to be a good candidate for the induction of CARS, since this cytokine is
capable of downregulating monocyte HLA-DR expression in vitro 48. In view of the
lack of success of many experimental, usually anti-inflammatory therapies, insight into
the disease state by monitoring the expression of HLA-DR in combination with the
analysis of IL-10 plasma concentrations may be helpful in deciding whether to choose
pro- or anti-inflammatory therapy in these patients and may determine clinical
outcome.
In summary, although systemic vasculitis and sepsis, both being systemic inflammatory
disorders, are characterized by systemic activation of circulating leukocytes, these
disorders differ in the nature of leukocyte activation, i.e. pro- or anti-inflammatory
response, the extent of leukocyte activation, i.e. priming or full activation, and the site
of leukocyte activation, i.e. at the endothelial lining or intravascularly. Vessel wall
injury in patients with vasculitis may, thus, result from endothelial injury due to
leukocyte activation at the endothelial lining, causing endothelial cell injury. In
contrast, vascular leakage in patients with sepsis may result from aberrant leukocyte
function, such as the inability to transmigratez3s' 23ó, which may lead to intravascular
leukocyte activation, i.e. release of toxic products as ROS, lytic enzymes and NO lra the
circulation, but not at the endothelial ining.
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